What is the Feasibility of the ISTEP Exercise Test in Boys With Haemophilia
NCT04076306 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 43
Last updated 2019-09-06
Summary
This study will be used to assess the feasibility and sensitivity of using the iSTEP, to assess exercise capacity in boys with haemophilia.
The feasibility criteria to be explored includes:
1. Recruitment to target number or better
2. The test procedure is completed within an allocated time (1-2 hours) and by 90% of participants without serious adverse events
3. 90% of participants achieve a sufficient exercise response (85% maximum heart rate (HRmax))
4. Calculation of estimates of minimum clinically important differences and variability for sample size calculations and responsiveness to severity of haemophilia and orthopaedic status The iSTEP exercise test will be compared to a more commonly used exercise test the modified shuttle walk test (10m- MSWT). Muscle strength (using myometry) will also be tested and compared to exercise performance for any relationships. Physical activity levels will also be assessed to obtain some baseline measurements of physical activity levels in this patient population, which are currently not very well known. The overarching aim of this current study is also to establish a robust and sensitive exercise test and to gain an understanding of the effects of physical activity levels and muscle strength on exercise capacity in this population.
Conditions
Interventions
- OTHER
-
iSTEP exercise testing
iSTEP 10 minute step test, up and down on a commercial standard 3-height adjustable step Undertaking the 10m-MSWT 20-30 minutes Procedure takes place on testing track at Great Ormond Street Hospital; a 5 minute walk from the Haemophilia Centre. One of the research team accompanies the family with child to the track and will accompany them back to the Centre once testing is finished. Muscle Myometry 10 minutes, carried out by one of the research team at the end of the physiotherapy clinical assessment in the Haemophilia Centre. Wearing of accelerometer (activity/ step counter)7 days Device will be set up and provided at the end of the testing on the day of attendance at clinic. They will be instructed to wear this throughout the week at home when they are awake (at least 8 hours). Haemophilia Joint Health Score (HJHS) - a standardised outcome measure of joint health in people with Haemophilia, undertaken by the Clinical Specialist Physiotherapists in Haemophilia.
Sponsors & Collaborators
-
University College, London
collaborator OTHER -
Great Ormond Street Hospital for Children NHS Foundation Trust
lead OTHER
Principal Investigators
-
Nicola Thorpe · Great Ormond Street Hospital
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 6 Years
- Max Age
- 15 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-01-25
- Primary Completion
- 2018-11-02
- Completion
- 2018-11-02
Countries
- United Kingdom
Study Locations
More Related Trials
-
Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Participants
NCT03876301 ·Status: COMPLETED
-
Preventing Inhibitor Recurrence Indefinitely
NCT04621916 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Non Substitutive Strategies to Improve Haemophilia Care in Developing Countries. Experience in Ivory Coast.
NCT03054662 ·Status: COMPLETED ·Phase: NA
-
iT-based Sports Therapy Application in Haemophilia
NCT04586101 ·Status: COMPLETED ·Phase: NA
-
An Exploration of the Impact of Gene Therapy on the Lives of People With Haemophilia and Their Families
NCT04723680 ·Status: COMPLETED
-
A Safety Study of STSP-0601 in Adult Patients With Hemophilia A or B With Inhibitor
NCT04747964 ·Status: COMPLETED ·Phase: PHASE1
-
Covalent Tolerance Induction to Factor VIII-Prediction of Inhibitors in Hemophilia
NCT00178607 ·Status: COMPLETED
-
Joint Outcome Study
NCT00207597 ·Status: COMPLETED
-
A Clinical Phenotype Based Individualized Prophylaxis in Chinese Hemophilia A Children
NCT02999308 ·Status: UNKNOWN ·Phase: PHASE4
-
A Progressive Resistance Training Program in Patients With Haemophilia
NCT02781233 ·Status: COMPLETED ·Phase: NA
-
Psychometric Validation of the Hemophilia Functional Ability Scoring Tool (Hemo-FAST)
NCT04731701 ·Status: COMPLETED
-
A Safety and Efficacy Study of STSP-0601 in Adult Patients With Hemophilia A or B With Inhibitor
NCT05027230 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Could Physical Activity Help to Counteract the Blood Haemophilia Disturbance? A Pilot Study.
NCT02851082 ·Status: COMPLETED ·Phase: NA
-
An Observational Study to Evaluate Physical Activity, Bleeding Incidence and Health Related Quality of Life, in Participants With Haemophilia A Without Inhibitors Receiving Standard of Care Treatment
NCT04165135 ·Status: COMPLETED
-
A Survey on the Success of Inhibitor Elimination Using Individualized Concentrate Selection and Controlled ITI
NCT02207894 ·Status: RECRUITING
-
TFPI Levels in Haemophilia A and B Patients
NCT04570696 ·Status: UNKNOWN
-
Global Hemostatic Methods in Hemophilia and Von Willebrand's Disease
NCT02061033 ·Status: UNKNOWN
-
Gait Examination in Patients With Hemophilia in Austria
NCT03541811 ·Status: COMPLETED
-
Individualizing Hemophilia Bypassing Agent Therapy Utilizing Thromboelastography
NCT03002480 ·Status: WITHDRAWN ·Phase: NA
-
Safety and Efficacy of STSP-0601 in Adult Patients with Hemophilia a or B with Inhibitor
NCT06289166 ·Status: COMPLETED ·Phase: PHASE2
-
Prophylaxis Versus on Demand Treatment for Children With Hemophilia A
NCT01810666 ·Status: COMPLETED ·Phase: PHASE4
-
Extension at 10 Years of the: "Observational Study Evaluating Efficacy and Costs of Secondary Prophylaxis vs On-demand Therapy With Kogenate Bayer in Patients With Severe Haemophilia A."
NCT02581969 ·Status: COMPLETED
-
A Long-Term Follow-Up Study of Haemophilia B Patients Who Have Undergone Gene Therapy
NCT03641703 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy Clinical Study of Severe Hemophilia B Treatment With KL001
NCT06125756 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
A Study to Evaluate the Safety and Pharmacokinetic of Recombinant Human Coagulation Factor VIII ,Fc Fusion Protein for Injection
NCT05251090 ·Status: COMPLETED ·Phase: PHASE1